These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 362055)

  • 1. Thyroid disease in relation to breast cancer.
    Vorherr H
    Klin Wochenschr; 1978 Dec; 56(23):1139-45. PubMed ID: 362055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of thyroid disease and use of thyroid supplements to breast cancer risk.
    Brinton LA; Hoffman DA; Hoover R; Fraumeni JF
    J Chronic Dis; 1984; 37(12):877-93. PubMed ID: 6526927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implication from thyroid function decreasing during chemotherapy in breast cancer patients: chemosensitization role of triiodothyronine.
    Huang J; Jin L; Ji G; Xing L; Xu C; Xiong X; Li H; Wu K; Ren G; Kong L
    BMC Cancer; 2013 Jul; 13():334. PubMed ID: 23829347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of breast cancer in thyroid cancer patients.
    Chalstrey LJ; Benjamin B
    Br J Cancer; 1966 Dec; 20(4):670-5. PubMed ID: 5964601
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hormonal therapy in oncologic treatment: pathogenic hypotheses and interactions between thyroid and breast pathologies].
    Parmeggiani D; Malinconico FA; Moccia G; Idà DN; Ripa C; Scala R; Foroni F; Gilio F; Cognetti C; Iside G; Agresti M
    Tumori; 2003; 89(4 Suppl):215-9. PubMed ID: 12903598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer in hypothyroid women using thyroid supplements.
    Hoffman DA; McConahey WM; Brinton LA; Fraumeni JF
    JAMA; 1984 Feb; 251(5):616-9. PubMed ID: 6690834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATA statement on breast cancer and thyroid hormone therapy.
    J Pediatr; 1977 Apr; 90(4):683-4. PubMed ID: 839405
    [No Abstract]   [Full Text] [Related]  

  • 8. Profile of thyroid hormones in breast cancer patients.
    Saraiva PP; Figueiredo NB; Padovani CR; Brentani MM; Nogueira CR
    Braz J Med Biol Res; 2005 May; 38(5):761-5. PubMed ID: 15917958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Breast neoplasms and thyroid therapy].
    Reinwein D
    Dtsch Med Wochenschr; 1980 Apr; 105(17):581-5. PubMed ID: 7371503
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of hormones in the etiology of human breast cancer.
    Kirschner MA
    Cancer; 1977 Jun; 39(6 Suppl):2716-26. PubMed ID: 326377
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe but not mild alterations of thyroid function modulate the density of thyroid-stimulating hormone receptors in the rat thyroid gland.
    Denereaz N; Lemarchand-Beraud T
    Endocrinology; 1995 Apr; 136(4):1694-700. PubMed ID: 7895680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of thyroid dysfunction on breast cancer risk: an updated meta-analysis.
    Tran TV; Kitahara CM; Leenhardt L; de Vathaire F; Boutron-Ruault MC; Journy N
    Endocr Relat Cancer; 2023 Jan; 30(1):. PubMed ID: 36256851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns off recovery of the hypothalamic-pituitary-thyroid axis in patients taken of chronic thyroid therapy.
    Krugman LG; Hershman JM; Chopra IJ; Levine GA; Pekary E; Geffner DL; Chua Teco GN
    J Clin Endocrinol Metab; 1975 Jul; 41(1):70-80. PubMed ID: 807596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer. Relationship to thyroid supplements for hypothyroidism.
    Kapdi CC; Wolfe JN
    JAMA; 1976 Sep; 236(10):1124-7. PubMed ID: 988872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of thyroid status and paraventricular area lesions on the release of thyrotropin-releasing hormone and catecholamines into hypophysial portal blood.
    Rondeel JM; de Greef WJ; van der Schoot P; Karels B; Klootwijk W; Visser TJ
    Endocrinology; 1988 Jul; 123(1):523-7. PubMed ID: 3133200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperthyroidism, Hypothyroidism, and Cause-Specific Mortality in a Large Cohort of Women.
    Journy NMY; Bernier MO; Doody MM; Alexander BH; Linet MS; Kitahara CM
    Thyroid; 2017 Aug; 27(8):1001-1010. PubMed ID: 28578598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased levothyroxine requirement in women with hypothyroidism during androgen therapy for breast cancer.
    Arafah BM
    Ann Intern Med; 1994 Aug; 121(4):247-51. PubMed ID: 7518657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of recovery of the hypothalamic-pituitary-thyroid axis following radioactive iodine therapy in patients with Graves' disease.
    Uy HL; Reasner CA; Samuels MH
    Am J Med; 1995 Aug; 99(2):173-9. PubMed ID: 7625422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between thyroid gland diseases and breast cancer: a case-control study.
    Bach L; Kostev K; Schiffmann L; Kalder M
    Breast Cancer Res Treat; 2020 Jul; 182(1):207-213. PubMed ID: 32424720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. American Thyroid Association statement on breast cancer and thyroid hormone therapy.
    Gorman CA; Becker DV; Greenspan FS; Levy RP; Oppenheimer JH; Rivlin RS; Robbins J; van der Laan WP
    Am J Surg; 1977 Nov; 134(5):622-3. PubMed ID: 920893
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.